Home
/
JRSIS HEALTH CARE Corp
/
Financials
/
Quarterly
JRSIS HEALTH CARE Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that JRSIS HEALTH CARE Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$222.9K
Dec 20, 2024
Q2
2024
Jun 30, 2024
$597.4K
Sep 5, 2024
Q1
2024
Mar 31, 2024
$500.4K
May 29, 2024
Q3
2024
Sep 30, 2023
$497.4K
Dec 20, 2024
Q2
2024
Jun 30, 2023
$337.4K
Sep 5, 2024
Q1
2024
Mar 31, 2023
$477.0K
May 29, 2024
Q1
2022
Mar 31, 2022
$15.62M
May 20, 2022
Q3
2021
Sep 30, 2021
$12.16M
Nov 15, 2021
Q2
2021
Jun 30, 2021
$11.74M
Aug 20, 2021
Q1
2022
Mar 31, 2021
$7.33M
May 20, 2022
Q3
2021
Sep 30, 2020
$10.02M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$7.02M
Aug 20, 2021
Q3
2018
Sep 30, 2018
$6.77M
Nov 13, 2018
Q2
2018
Jun 30, 2018
$7.02M
Aug 13, 2018
Q3
2018
Sep 30, 2017
$5.72M
Nov 13, 2018
Q2
2018
Jun 30, 2017
$5.36M
Aug 13, 2018
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$6.80M
May 14, 2018
Q3
2017
Sep 30, 2017
$5.72M
Nov 13, 2017
Q2
2017
Jun 30, 2017
$5.36M
Aug 14, 2017
Q1
2018
Mar 31, 2017
$5.51M
May 14, 2018
Q3
2017
Sep 30, 2016
$4.26M
Nov 13, 2017
Q2
2017
Jun 30, 2016
$4.29M
Aug 14, 2017
Q1
2017
Mar 31, 2016
$4.41M
May 15, 2017
Q3
2016
Sep 30, 2015
$2.93M
Nov 14, 2016
Q2
2016
Jun 30, 2015
$2.71M
Aug 15, 2016
Q1
2016
Mar 31, 2015
$2.43M
May 16, 2016
Q3
2015
Sep 30, 2014
$1.37M
Nov 16, 2015
Q2
2015
Jun 30, 2014
$1.54M
Aug 14, 2015
Q1
2015
Mar 31, 2014
$1.53M
May 12, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($188.1K)
Dec 20, 2024
Q2
2024
Jun 30, 2024
($102.4K)
Sep 5, 2024
Q1
2024
Mar 31, 2024
($145.4K)
May 29, 2024
Q3
2024
Sep 30, 2023
$33.7K
Dec 20, 2024
Q2
2024
Jun 30, 2023
($106.0K)
Sep 5, 2024
Q1
2024
Mar 31, 2023
$45.4K
May 29, 2024
Q3
2023
Sep 30, 2022
($132.5K)
Nov 15, 2023
Q2
2023
Jun 30, 2022
($36.18M)
Aug 21, 2023
Q1
2023
Mar 31, 2022
$2.64M
May 22, 2023
Q2
2022
Mar 31, 2022
$2.64M
Sep 15, 2022
Q3
2021
Sep 30, 2021
$541.5K
Nov 15, 2021
Q2
2022
Jun 30, 2021
$1.02M
Sep 15, 2022
Q3
2021
Jun 30, 2021
$1.02M
Nov 15, 2021
Q1
2022
Mar 31, 2021
$495.9K
May 20, 2022
Q2
2022
Mar 31, 2021
$495.9K
Sep 15, 2022
Q3
2021
Mar 31, 2021
$495.9K
Nov 15, 2021
Q3
2021
Sep 30, 2020
$1.03M
Nov 15, 2021
Q3
2021
Jun 30, 2020
$403.1K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$403.1K
Aug 20, 2021
Q2
2021
Mar 31, 2020
$314.9K
Aug 20, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($206.2K)
Dec 20, 2024
Q2
2024
Jun 30, 2024
($118.7K)
Sep 5, 2024
Q1
2024
Mar 31, 2024
($160.9K)
May 29, 2024
Q3
2024
Sep 30, 2023
$51.0K
Dec 20, 2024
Q2
2024
Jun 30, 2023
($127.3K)
Sep 5, 2024
Q1
2024
Mar 31, 2023
$77.5K
May 29, 2024
Q3
2023
Sep 30, 2022
($132.5K)
Nov 15, 2023
Q2
2023
Jun 30, 2022
($127.3K)
Aug 21, 2023
Q1
2023
Mar 31, 2022
($22.3K)
May 22, 2023
Q3
2022
Sep 30, 2021
($7.5K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.5K)
Sep 15, 2022
Q1
2022
Mar 31, 2021
$706.3K
May 20, 2022
Q3
2021
Sep 30, 2020
$1.88M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$653.7K
Aug 20, 2021
Q1
2021
Mar 31, 2020
$376.5K
May 14, 2021
Q3
2020
Sep 30, 2019
$1.07M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$1.27M
Aug 14, 2020
Q1
2020
Mar 31, 2019
$1.22M
Jun 29, 2020
Q3
2019
Sep 30, 2018
$1.58M
Nov 13, 2019
Q2
2019
Jun 30, 2018
$2.05M
Sep 20, 2019